Literature DB >> 26283705

Three dimensional de novo micro bone marrow and its versatile application in drug screening and regenerative medicine.

Guanqun Li1, Xujun Liu1, Qian Du2, Mei Gao3, Jing An4.   

Abstract

The finding that bone marrow hosts several types of multipotent stem cell has prompted extensive research aimed at regenerating organs and building models to elucidate the mechanisms of diseases. Conventional research depends on the use of two-dimensional (2D) bone marrow systems, which imposes several obstacles. The development of 3D bone marrow systems with appropriate molecules and materials however, is now showing promising results. In this review, we discuss the advantages of 3D bone marrow systems over 2D systems and then point out various factors that can enhance the 3D systems. The intensive research on 3D bone marrow systems has revealed multiple important clinical applications including disease modeling, drug screening, regenerative medicine, etc. We also discuss some possible future directions in the 3D bone marrow research field.
© 2015 by the Society for Experimental Biology and Medicine.

Keywords:  Three dimension; bone marrow; computational model; disease modeling; regenerative medicine; scaffold; stem cell

Mesh:

Year:  2015        PMID: 26283705      PMCID: PMC4935287          DOI: 10.1177/1535370215594583

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  105 in total

1.  Stem cell properties of human dental pulp stem cells.

Authors:  S Gronthos; J Brahim; W Li; L W Fisher; N Cherman; A Boyde; P DenBesten; P Gehron Robey; S Shi
Journal:  J Dent Res       Date:  2002-08       Impact factor: 6.116

Review 2.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

Review 3.  Three-dimensional cultures of osteogenic and chondrogenic cells: a tissue engineering approach to mimic bone and cartilage in vitro.

Authors:  F Tortelli; R Cancedda
Journal:  Eur Cell Mater       Date:  2009-06-30       Impact factor: 3.942

4.  Nov/CCN3 regulates long-term repopulating activity of murine hematopoietic stem cells via integrin αvβ3.

Authors:  Jun Ishihara; Terumasa Umemoto; Masayuki Yamato; Yoshiko Shiratsuchi; Satoshi Takaki; Brian G Petrich; Hiromitsu Nakauchi; Koji Eto; Toshio Kitamura; Teruo Okano
Journal:  Int J Hematol       Date:  2014-02-22       Impact factor: 2.490

5.  Fibroin protein/chitosan scaffolds and bone marrow mesenchymal stem cells culture in vitro.

Authors:  J Deng; R F She; W L Huang; C Yuan; G Mo
Journal:  Genet Mol Res       Date:  2014-07-29

Review 6.  Regulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche.

Authors:  Christina Schreck; Franziska Bock; Sandra Grziwok; Robert A J Oostendorp; Rouzanna Istvánffy
Journal:  Ann N Y Acad Sci       Date:  2014-02-25       Impact factor: 5.691

7.  Factors in human serum affecting the proliferation of normal and leukemic cells.

Authors:  P J Burke; C H Diggs; A H Owens
Journal:  Cancer Res       Date:  1973-04       Impact factor: 12.701

8.  Taking cell-matrix adhesions to the third dimension.

Authors:  E Cukierman; R Pankov; D R Stevens; K M Yamada
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

9.  Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate.

Authors:  Nathaniel Huebsch; Praveen R Arany; Angelo S Mao; Dmitry Shvartsman; Omar A Ali; Sidi A Bencherif; José Rivera-Feliciano; David J Mooney
Journal:  Nat Mater       Date:  2010-04-25       Impact factor: 43.841

10.  Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells.

Authors:  Aimin Meng; Yong Wang; Gary Van Zant; Daohong Zhou
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

View more
  1 in total

Review 1.  The extracellular matrix of hematopoietic stem cell niches.

Authors:  Cornelia Lee-Thedieck; Peter Schertl; Gerd Klein
Journal:  Adv Drug Deliv Rev       Date:  2021-11-25       Impact factor: 15.470

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.